AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data
AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device ...
Business Wire13d
AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data
The investigational technology uses Lead I ECG data to alert patients and clinicians of moderate to severe episodes of hyperkalemia (excess potassium in the blood) that can lead to sudden cardiac ...
MassDevice13d
AccurKardia wins FDA breakthrough nod for hyperkalemia detection software
AccurKardia announced that it received FDA breakthrough device designation for its ECG-based, AI-powered hyperkalemia ...
Morningstar13d
AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data
AccurKardia's AK+ Guard is designed to work with a wide range of FDA-cleared consumer and clinical wearables that currently capture Lead I ECG data (e.g., smartwatches), enabling hyperkalemia ...
Monthly Prescribing Reference27d
Klor-con Powder
Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers. Hyperkalemia with ACE inhibitors, spironolactone ...